These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 21222164)

  • 21. Sucrose gradient analysis of phospholipid-activated beta-glucosidase in type 1 and type 2 Gaucher's disease.
    Garrett KO; Prence EM; Glew RH
    Arch Biochem Biophys; 1985 Apr; 238(1):344-52. PubMed ID: 3920967
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heterogeneity in human acid beta-glucosidase revealed by cellulose-acetate electrophoresis.
    Sa Miranda MC; Aerts JM; Pinto RA; Magalhaes JA; Barranger JA; Tager JM; Schram AW
    Biochim Biophys Acta; 1988 May; 965(2-3):163-8. PubMed ID: 3130106
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gaucher's disease. I. Modern enzymatic and anatomic methods of diagnosis.
    Lee RE; Robinson DB; Glew RH
    Arch Pathol Lab Med; 1981 Feb; 105(2):102-4. PubMed ID: 6779779
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fluorimetric urease inhibition assay on a multilayer microfluidic chip with immunoaffinity immobilized enzyme reactors.
    Zhang Q; Tang X; Hou F; Yang J; Xie Z; Cheng Z
    Anal Biochem; 2013 Oct; 441(1):51-7. PubMed ID: 23792035
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Separation by electrofocusing of the molecular forms of splenic beta-glucosidase in normal subjects and Gaucher's disease].
    Maret A; Salvayre R; Nègre A; Douste-Blazy L
    Biomedicine; 1980 May; 33(3):82-6. PubMed ID: 6778520
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A modified method for the identification of heterozygotes for Gaucher's disease using differential thermal inactivation.
    Goodman C; O'Brien JS
    Clin Genet; 1980 Sep; 18(3):226-31. PubMed ID: 6777098
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of activators and inhibitors to define the properties of the active site of normal and Gaucher disease lysosomal beta-glucosidase.
    Gatt S; Dinur T; Osiecki K; Desnick RJ; Grabowski GA
    Enzyme; 1985; 33(2):109-19. PubMed ID: 3924590
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gaucher disease: the effects of phosphatidylserine on glucocerebrosidase from normal and Gaucher fibroblasts.
    Choy FY
    Hum Genet; 1984; 67(4):432-6. PubMed ID: 6436168
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acid beta-glucosidase and the diagnosis of Gaucher's disease in liver and spleen.
    Butterworth J; Broadhead DM
    Clin Chim Acta; 1978 Aug; 87(3):433-40. PubMed ID: 28186
    [TBL] [Abstract][Full Text] [Related]  

  • 30. beta-Glucosidase activities in the Norrbotten type of juvenile Gaucher's disease.
    Hultberg B
    Acta Neurol Scand; 1978 Aug; 58(2):89-94. PubMed ID: 30251
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of N-acyl phosphatidylethanolamines with different N-acyl groups as activators of glucocerebrosidase in various forms of Gaucher's disease.
    Basu A; Prence E; Garrett K; Glew RH; Ellingson JS
    Arch Biochem Biophys; 1985 Nov; 243(1):28-34. PubMed ID: 3933429
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cholesterol glucosylation is catalyzed by transglucosylation reaction of β-glucosidase 1.
    Akiyama H; Kobayashi S; Hirabayashi Y; Murakami-Murofushi K
    Biochem Biophys Res Commun; 2013 Nov; 441(4):838-43. PubMed ID: 24211208
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gaucher's disease. I. Solubilization and electrophoresis of beta-glucosidase from leukocytes and cultured fibroblasts.
    Choy FY; Davidson RG
    Pediatr Res; 1978 Dec; 12(12):1115-20. PubMed ID: 106357
    [No Abstract]   [Full Text] [Related]  

  • 34. [Gaucher's disease (type 1) with clinical picture like a myelodysplastic syndrome: the difference between this Gaucher's cell and CML pseudo-Gaucher's cell].
    Saito H; Uemura K; Maruyama T; Kawakami H; Iijima Y; Kitano K; Kaji R; Furuta S
    Rinsho Ketsueki; 1987 Aug; 28(8):1449-55. PubMed ID: 3123742
    [No Abstract]   [Full Text] [Related]  

  • 35. Assay of the beta-glucosidase activity with natural labelled and artificial substrates in cultivated skin fibroblasts from homozygotes and heterozygotes with the Norrbottnian type of Gaucher disease.
    Håkansson G; Dreborg S; Lindsten J; Svennerholm L
    Clin Genet; 1980 Oct; 18(4):268-73. PubMed ID: 6777099
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnosis of Gaucher's disease in cultured skin fibroblasts and leucocytes.
    Butterworth J; Broadhead DM
    J Inherit Metab Dis; 1978; 1(3):111-3. PubMed ID: 116079
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biochemical properties of beta-glucosidase in leukocytes from patients and obligated heterozygotes for Gaucher disease carriers.
    Michelin K; Wajner A; Bock H; Fachel A; Rosenberg R; Pires RF; Pereira ML; Giugliani R; Coelho JC
    Clin Chim Acta; 2005 Dec; 362(1-2):101-9. PubMed ID: 16039637
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Gaucher's disease suspected by abdominal echography findings].
    Castellano G; Yela MC; Martín A; Manzano ML; Colina F; Solís JA
    Gastroenterol Hepatol; 1998 Apr; 21(4):184-7. PubMed ID: 9633179
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The enzymatic hydrolysis of 6-acylamino-4-methylumbelliferyl-beta-D-glucosides: identification of a novel human acid beta-glucosidase.
    Mikhaylova M; Wiederschain G; Mikhaylov V; Aerts JM
    Biochim Biophys Acta; 1996 Oct; 1317(1):71-9. PubMed ID: 8876629
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of the activation of rat liver beta-glucosidase by sialosylgangliotetraosylceramide.
    Basu A; Glew RH
    J Biol Chem; 1985 Oct; 260(24):13067-73. PubMed ID: 3932339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.